8-K: MedMen Enterprises Appoints Chief Restructuring Officer Amid Financial Challenges

MedMen Enterprises has appointed Richard P. Ormond as Chief Restructuring Officer to navigate the company's financial difficulties.

Summary

• MedMen Enterprises has engaged Richard P. Ormond as its Chief Restructuring Officer, effective January 23, 2024.
• Mr. Ormond will provide restructuring services through his firm, Stone Blossom Capital, LLC (SBC).
• MedMen will pay SBC a non-refundable initial payment of $180,000 for the first four months of services.
• Following the initial four months, SBC will receive $45,000 per month until the termination of the consulting agreement.
• The consulting agreement has a minimum initial term of six months and can be renewed monthly or terminated with ten days' written notice.
• MedMen has also engaged Buchalter, APC, where Mr. Ormond is a shareholder, for legal services.
• Mr. Ormond has extensive experience in the cannabis industry, including roles in receivership, restructuring, and teaching cannabis business law.

Sentiment

Score: 3

Explanation: The appointment of a Chief Restructuring Officer and the associated costs suggest significant financial challenges, leading to a negative sentiment.

Positives

• The appointment of a Chief Restructuring Officer indicates a proactive approach to addressing the company's financial challenges.
• Richard P. Ormond has extensive experience in the cannabis industry, which could be beneficial for MedMen's restructuring efforts.
• The consulting agreement provides a clear framework for the restructuring process.

Negatives

• The engagement of a Chief Restructuring Officer suggests that MedMen is facing significant financial difficulties.
• The company is incurring substantial costs for restructuring services, including an initial payment of $180,000 and ongoing monthly payments of $45,000.
• The engagement of Buchalter, APC for legal services, where the CRO is a shareholder, could raise potential conflict of interest concerns.

Risks

• The restructuring process may be complex and time-consuming, with no guarantee of success.
• The company's financial situation may worsen if the restructuring efforts are not effective.
• There is a risk that the company may not be able to meet its financial obligations, including payments to the restructuring consultant.
• The company's secured lender has guaranteed the fees due to the consultant, indicating a potential risk for the lender.

Future Outlook

The document outlines the terms of the consulting agreement for restructuring services, but does not provide specific forward-looking statements about the company's future performance or financial position.

Management Comments

• The board of directors of MedMen Enterprises Inc. appointed Richard P. Ormond as its Chief Restructuring Officer.
• The company agreed to pay SBC a non-refundable initial payment of $180,000 for the first four months of services and $45,000 per month thereafter.

Industry Context

The appointment of a Chief Restructuring Officer is not uncommon for companies in the cannabis industry facing financial challenges, as the sector is known for its volatility and regulatory complexities. This move suggests MedMen is taking steps to address its financial issues, which is a trend seen across the industry.

Comparison to Industry Standards

• The engagement of a CRO is a common practice for companies facing financial distress, similar to other companies in the cannabis industry and other sectors.
• The fee structure of $180,000 upfront and $45,000 per month is within the range of what is typically seen for restructuring engagements of this nature, although specific comparisons are difficult without knowing the full scope of the work.
• The use of a consulting firm with experience in the cannabis industry is a common practice, as it provides specialized knowledge and expertise.

Management Changes

Stakeholder Impact

• Shareholders may experience further losses due to the company's financial difficulties and potential restructuring.
• Employees may face job losses as the company restructures or winds down operations.
• Creditors may face losses if the company is unable to meet its financial obligations.
• Customers may experience disruptions in service or product availability.

Next Steps

• The Chief Restructuring Officer will develop and implement a restructuring or insolvency plan.
• The company will work with the consultant to assess assets and develop a plan for the orderly winddown of operations.
• The company will coordinate with legal counsel for any proceedings on behalf of the company.

Key Dates

Keywords

restructuring, chief restructuring officer, cannabis industry, financial difficulties, consulting agreement, insolvency, MedMen Enterprises, Stone Blossom Capital, Buchalter APC